Why rcts are gold standard




















A therapy that is found to be effective in treating diabetic foot ulcers in patients with a hemoglobin A1c HbA1c of 7. How many RCTs have been proclaimed to change the way we treat diseases, only to be completely reversed within a few years? When was the last time you saw the results of a large RCT that reported a negative result? This lack of reporting of negative outcomes discourages investigation of complicated and unusual projects and treatments and, more importantly, it may result in pressure on investigators to falsify their results.

The gold standard should be the one you determine for yourself with your own investigation. Sign in. Podiatry Today. Today's Wound Clinic. Symposium on Advanced Wound Care. Current Research. Online Exclusives. PolyNovo Video Library. Journal Description. Editorial Board. Submission Information. Contact Us. Advertising Opportunities.

Subscribe to E-News. Start Print Subscription. Renew Print Subscription. Terry Treadwell. Keywords Editorial Message. Dear Readers. Submit Feedback. Email Address. Just when many of us thought we saw a light at the end of the COVID pandemic tunnel, the rate of immunizations declined and a more contagious variant of the virus found enough susceptible hosts to start another wave of illness and death.

Depending on where you live, you already witnessed the veracity of the Delta variant, are in the middle of trying to deal with it, or are starting to see and Everyone who had the honor and pleasure of working with Barbara Braden experienced her thoughtfulness, kindness, and generosity of spirit. She readily shared everything she knew to improve patient care.

Sharing what we know comes naturally to health care professionals. We share what we know with patients, caregivers, colleagues, and students, not to mention our relatives, neighbors, friends, and acquaintances looking for a second or first opinion.

We rely on colleagues and trusted resources to stay up-to-date on developments in our own specialty area, the practice of health care in general, as Featured Video. Such effects are not a problem unique to Medicine, because each and every trial in orthodontics also requires an informed consent and in addition, as indicated above, can neither be blinded nor double blinded.

In turn both the patients and the operators will adapt their behaviour and attitudes, which will influence the results to a clinically significant extent also in for orthodontics. A very good example for this interrelation can be seen in the RCT by Sandler et al. Before treatment both groups had similar PAR-scores. The results revealed, comparable amounts of PAR-score reduction in both groups thus, both the headgear and the palatal implant were equally effective.

There was also no difference in treatment length between the groups—thus also the efficiency of the two treatment modalities was equal. But is this really true? It is some sort of truth, but not clinical truth, it is a truth modified by the trial condition itself because, as Sandler et al. Changes mm in VAS pain levels after naproxen or placebo intake in patients with and without informed consent [adapted from Bergmann et al. The Hawthorne effect refers to a phenomenon whereby individuals improve or modify their behaviour in response to their awareness of being observed We must be aware of the fact, that RCTs in orthodontics are extremely susceptible to Hawthorne effects, because every orthodontic treatment success depends to some extent on patient cooperation.

So given a trial changes cooperation, all orthodontic treatment modalities requiring cooperation cannot be tested reliably using a RCT design, at least not if we are seeking clinically relevant truth.

So we have to accept, that for many orthodontic research questions it will either not be possible at all or not be sensible to conduct a RCTs, because of the difficulties associated with undertaking them 22 :.

The above mentioned arguments naturally raise the question where to go from here, or in other words, what kind of research to perform in the future. So walking down the hierarchy of evidence ladder in our mind Figure 1 , the next type of studies to reflect about would be cohort studies or in other words non-randomized prospective studies.

However, the only main difference between cohort studies and RCTs is the type of allocation, which is not random. This in turn means, that from the point of view of orthodontics the majority of the aforementioned disadvantages of RCTs apply to cohort studies as well.

So this brings us down to the level of case—control studies and retrospective studies. However, not in the way we have done in times past but by improving the quality of retrospective clinical studies. If we compare RCTs, cross-sectional studies, cohort studies and case—control studies it become clear, that the three types of observational studies have the potential for a higher external validity than RCTS or in other words a higher degree to which the derived data can be extrapolated to the general population, which is of course desirable.

So how can we improve retrospective studies? Instead of investing millions of euros, dollars, or pounds in RCTs only, we could alternatively or additionally invest in a sort of International Orthodontic Registry in which the registration of orthodontic cases with clearly defined malocclusion characteristics would be compulsory. Nevertheless, also such registry studies are of course not bias-free but they are a primary source for population-based case—control studies with several advantages, the most important ones being 25 :.

Arguments about the relative importance of each are an unnecessary distraction. Sackett D. Rosenberg W. Gray J. Haynes R. BMJ Clinical Research ed. Google Scholar. Evidence-Based Medicine Working Group. Journal of American Medical Association , , — Ackerman M.

Journal of the American Dental Association , , — ; quiz British Journal of Orthodontics , 22 , — Marshall G. British Medical Journal , 2 , — Koletsi D. Pandis N. Polychronopoulou A. An assessment of whether randomized controlled trial in a title means that it is one. American Journal of Orthodontics and Dentofacial Orthopedics , , — Ioannidis J. Google Preview.

Richardson W. Churchill-Livingstone , London , p. Sami T. Opticon , 11 , 1 — Kaptchuk T. Journal of Clinical Epidemiology , 54 , — The Samurai Radiologist. Meikle M. A personal viewpoint. European Journal of Orthodontics , 27 , — Johnston L. Journal of Orthodontics , 29 , — Smith G. Hughes J. Gulliver S. Amori G. Mireault G. Psychopharmacology , 99 , — Scott C. Walker J.

White P. Bergmann J. Clinical Trials and Meta-analysis , 29 , 41 — Sandler J. American Journal of Orthodontics and Dentofacial Orthopedics , , 51 — McCarney R.

Warner J. Iliffe S. Griffin M. This confusion of effects is known as confounding , and randomisation is used to overcome it. In randomised trials, treatments are randomly allocated to the trial participants, so each individual has the same chance of receiving the new or standard treatment.

Randomisation ensures the the people in each group have a similar distribution of characteristics to make sure that the groups are comparable - so if one group has better outcomes than the other, it can be attributed to the interventions being tested. Randomisation is therefore critical to make direct comparisons between the treatments. It is also important that the treatment allocation is concealed from both the patient and doctor before the patient joins the study so that this cannot influence the decision for the patient to take part in the study.

The control group is the one the new treatment is being compared with. So, people in this group generally receive the standard treatment for treating the disease of interest. If there is no standard treatment, the control group may receive either no treatment at all or a placebo an identical treatment but with no active ingredient. The presence of a control group is important to understand what happens to similar patients who undergo the same procedures as in the other group s , but in the absence of the new treatment.

Ideally in a randomised controlled trial, the treatment is masked from the patient and the medical staff treating the participant. This is known as blinding.



0コメント

  • 1000 / 1000